By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cardio3 BioSciences 

Parc de L’Alliance
9, Boulevard de France
Braine - L’Alleud    1420  Belgium
Phone: 32-2-790-35-30 Fax: 32-2-790-35-35



Company News
Cardio3 BioSciences Receives Approval For The Continuation Of Its Chart-1 Phase III Clinical Trial From The DSMB 9/15/2014 11:09:52 AM
Cardio3 BioSciences Reports 2014 Half Year Financial Results And Business Update 8/22/2014 12:31:56 PM
Cardio3 BioSciences Announces Secondary Placement With New Institutional Investors 7/9/2014 10:42:19 AM
Cardio3 BioSciences To Enroll The 120th Patient For Its CHART-1 Study 7/7/2014 10:24:55 AM
Cardio3 BioSciences Announces Completion Of Its Capital Increase Of €25 Million At €44 Per Share 7/1/2014 9:23:47 AM
Cardio3 BioSciences Teams Up With Medisun International To Create Cardio3 Biosciences Asia Holdings Ltd, A Joint Venture Aimed At Conducting Pivotal Clinical Programs In Greater China 6/16/2014 9:06:05 AM
Cardio3 BioSciences Announces A Capital Increase Of €25 Million At €44 Per share. 6/16/2014 8:59:18 AM
Cardio3 BioSciences, A European Biopharmaceutical Company, Now Covered By Edison Investment Research 1/8/2014 9:57:41 AM
Cardio3 BioSciences Announces Participation At The 32nd Annual JP Morgan Healthcare Conference In San Francisco 12/30/2013 6:28:45 AM
Cardio3 BioSciences Announces Q3 2013 Business Update And Authorization To Enroll Patients In Poland In Its Chart-1 Phase III Clinical Trial 11/13/2013 8:57:55 AM